BLNK vs. ALT

Last updated Apr 1, 2026

Compare and contrast key facts about Blink Charging Co. (BLNK) and Altimmune, Inc. (ALT).

Performance

BLNK vs. ALT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Blink Charging Co. (BLNK) and Altimmune, Inc. (ALT). The values are adjusted to include any dividend payments, if applicable.

BLNK vs. ALT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
BLNK Blink Charging Co.	-15.01%	-52.01%	-59.00%	-69.10%	-58.62%	-37.99%	2,198.39%	8.14%	-79.79%
ALT Altimmune, Inc.	-14.68%	-49.93%	-35.91%	-31.61%	79.59%	-18.79%	496.83%	-8.25%	-95.10%

Fundamentals

EPS BLNK : -$0.75 ALT : -$0.97
PS Ratio BLNK : 0.39 ALT : 6.80K
Total Revenue (TTM) BLNK : $103.52M ALT : $41.00K
Gross Profit (TTM) BLNK : $25.50M ALT : -$14.95M
EBITDA (TTM) BLNK : -$54.80M ALT : -$89.46M

Returns By Period

The year-to-date returns for both investments are quite close, with BLNK having a -15.01% return and ALT slightly higher at -14.68%.

BLNK

• 1D: 13.06%
• 1M: -14.26%
• YTD: -15.01%
• 6M: -65.43%
• 1Y: -38.23%
• 3Y*: -59.68%
• 5Y*: -57.58%
• 10Y*: —

ALT

• 1D: 6.94%
• 1M: -28.54%
• YTD: -14.68%
• 6M: -18.30%
• 1Y: -38.40%
• 3Y*: -9.96%
• 5Y*: -26.13%
• 10Y*: -40.86%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

BLNK vs. ALT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BLNK

BLNK Risk / Return Rank: 27
BLNK Sharpe Ratio Rank: 24
BLNK Sortino Ratio Rank: 28
BLNK Omega Ratio Rank: 29
BLNK Calmar Ratio Rank: 26
BLNK Martin Ratio Rank: 27

ALT

ALT Risk / Return Rank: 26
ALT Sharpe Ratio Rank: 23
ALT Sortino Ratio Rank: 31
ALT Omega Ratio Rank: 32
ALT Calmar Ratio Rank: 18
ALT Martin Ratio Rank: 24

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BLNK vs. ALT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Blink Charging Co. (BLNK) and Altimmune, Inc. (ALT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BLNK	ALT	Difference
Sharpe ratio Return per unit of total volatility	-0.40	-0.41	+0.01
Sortino ratio Return per unit of downside risk	-0.08	0.05	-0.13
Omega ratio Gain probability vs. loss probability	0.99	1.01	-0.02
Calmar ratio Return relative to maximum drawdown	-0.49	-0.67	+0.18
Martin ratio Return relative to average drawdown	-0.90	-1.02	+0.13
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BLNK vs. ALT - Sharpe Ratio Comparison

The current BLNK Sharpe Ratio is -0.40, which is comparable to the ALT Sharpe Ratio of -0.41. The chart below compares the historical Sharpe Ratios of BLNK and ALT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	BLNK	ALT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.40	-0.41	+0.01
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.70	-0.28	-0.42
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.29	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.23	-0.24	+0.01

Correlation

The correlation between BLNK and ALT is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

BLNK vs. ALT - Dividend Comparison

Neither BLNK nor ALT has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

BLNK vs. ALT - Drawdown Comparison

The maximum BLNK drawdown since its inception was -99.17%, roughly equal to the maximum ALT drawdown of -99.94%. Use the drawdown chart below to compare losses from any high point for BLNK and ALT.

Drawdown Indicators

	BLNK	ALT	Difference
Max Drawdown Largest peak-to-trough decline	-99.17%	-99.94%	+0.77%
Max Drawdown (1Y) Largest decline over 1 year	-79.94%	-62.65%	-17.29%
Max Drawdown (5Y) Largest decline over 5 years	-98.93%	-90.45%	-8.48%
Max Drawdown (10Y) Largest decline over 10 years	—	-99.85%	—
Current Drawdown Current decline from peak	-99.07%	-99.89%	+0.82%
Average Drawdown Average peak-to-trough decline	-72.46%	-80.66%	+8.20%
Ulcer Index Depth and duration of drawdowns from previous peaks	43.99%	41.12%	+2.87%

Volatility

BLNK vs. ALT - Volatility Comparison

Blink Charging Co. (BLNK) has a higher volatility of 31.32% compared to Altimmune, Inc. (ALT) at 26.59%. This indicates that BLNK's price experiences larger fluctuations and is considered to be riskier than ALT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BLNK	ALT	Difference
Volatility (1M) Calculated over the trailing 1-month period	31.32%	26.59%	+4.73%
Volatility (6M) Calculated over the trailing 6-month period	70.56%	58.39%	+12.17%
Volatility (1Y) Calculated over the trailing 1-year period	94.94%	93.96%	+0.98%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	82.73%	94.38%	-11.65%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	121.98%	142.47%	-20.49%

Financials